BACKGROUND: Antitachycardia pacing (ATP) can reduce implantable cardioverter-
defibrillator shocks, but its use in children and patients with congenital heart disease (CHD) …

Implantable cardioverter‐defibrillators (ICDs) improve survival when used as primary or
secondary prevention therapy in patients with a broad spectrum of disorders associated with …

Antitachycardia pacing (ATP) strategies represent safe, effective, and painless therapy for
ventricular tachyarrhythmias, with a large body of clinical evidence supporting their routine …

Abstract Purpose of Review Implantable cardioverter-defibrillator (ICD) shocks, whether
appropriate or inappropriate, are associated with significant morbidity and mortality. Anti …

Introduction and objectives Fast ventricular tachycardias in the ventricular fibrillation zone in
patients with an implantable cardioverter-defibrillator are susceptible to antitachycardia …

Background Antitachycardia pacing (ATP) is routinely used to terminate ventricular
tachyarrhythmias (VTs). However, little guidance exists on the most effective programming of …

Cardiovascular implantable electronic devices have revolutionized the management of heart
failure with reduced ejection fraction. New device generations tend to be launched every few …

Implantable cardioverter-defibrillator therapy in the form of high-energy shock (HES) is
associated with adverse effects. This study evaluated an alternative therapy to HES …

AIM: Our manuscript proposes recommendations to standardise implantable cardioverter-
defibrillator (ICD) programming practice in New Zealand (NZ) and provides a review of the …

Статья посвящена методу профилактики внезапной сердечной смерти с помощью
имплантируемых кардиовертеров-дефибрилляторов. Исследуется проблема …